Xiao-Jun Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiao-Jun Yang has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
Fei-Lei Zhang
Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou city, Jiangsu Province, PR China
3 shared publicationsTian-Quan Chen
Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province 215006, PR China; Department of Obstetrics and Gynecology, The Affiliated Hospital of Yangzhou University, Yangzhou City, Jiangsu Province 225000, PR China
3 shared publicationsXiao-Jiao Wei
Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province 215006, PR China
3 shared publicationsXue-Ling Tang
Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou city, Jiangsu Province, PR China
3 shared publicationsYue-Lin Huang
Department of Obstetrics and Gynecology, The Affiliated Hospital of Guizhou Medical University, Guiyang City, Guizhou Province 550000, PR China
3 shared publicationsZong‐Ji Shen
Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou city, Jiangsu province, China
3 shared publications
Latest Publications
- 21 April 2026
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1872 (6) , 168272
Prophylactic systemic low-dose pirfenidone attenuates intrauterine adhesion by inhibiting the TGF-β1/Smad3 pathway
- 21 April 2026
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1872 (6) , 168272
Prophylactic systemic low-dose pirfenidone attenuates intrauterine adhesion by inhibiting the TGF-β1/Smad3 pathway
- 24 March 2026
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 32 (2)
Cyclic stretch activates endometrial stromal cells to enhance migration and invasion via mechanosensitive p38 MAPK and F-actin in vitro
Adenomyosis (AM) is traditionally explained by biochemical dysregulation at the endometrial–myometrial interface, leading to passive displacement of endometrial stromal cells (ESCs). However, the uterus is a highly mechanosensitive organ. Aberrant myometrial hypercontractility in AM may expose ESCs to chronic mechanical stimulation. Whether such mechanical cues can modulate ESCs’ behavior under in vitro conditions remains incompletely understood. This study hypothesizes that cyclic mechanical strain—independent of biochemical cues—can induce a pro-migratory and pro-invasive ESC phenotype in vitro. Immortalized human ESCs (hESCs) were subjected to cyclic uniaxial stretching (12% strain, 0.2 Hz, 48 h) to model sustained mechanical loading. We evaluated cellular morphology, migration and invasion (wound healing and Transwell assays), cytoskeletal remodeling (F-actin), extracellular matrix (ECM) related proteins, transcriptomic changes (RNA-sequencing), and MAPK pathway activation. The functional involvement of p38 MAPK was tested using the selective inhibitor Adezmapimod. The results indicated that cyclic stretch induced marked cellular elongation without increasing apoptosis. RNA-sequencing revealed 580 differentially expressed genes enriched in migration and ECM remodeling. Functionally, stretched hESCs exhibited enhanced migration and invasion capacity in vitro, accompanied by elevated F-actin, fibronectin, and CTGF. Mechanistically, mechanical strain triggered selective activation of the p38 MAPK pathway, without affecting ERK or JNK. Pharmacological inhibition of p38 attenuated stretch-associated cytoskeletal remodeling, ECM-related protein expression, and cell motility. Together, these findings demonstrate that cyclic mechanical stretch, as an underexplored non-biochemical factor, can promote a motile and invasive stromal cell phenotype in vitro via a p38 MAPK/F-actin-associated mechanism. While these results do not establish causality for AM development in vivo, they suggest a potential mechanotransduction pathway through which abnormal uterine mechanics may influence stromal cell behavior. Targeting mechanotransduction—such as p38 inhibition—may represent novel mechano-therapeutics for AM. This warrants further investigation using more complex and physiologically relevant models.
- 24 March 2026
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 32 (2)
Cyclic stretch activates endometrial stromal cells to enhance migration and invasion via mechanosensitive p38 MAPK and F-actin in vitro
Adenomyosis (AM) is traditionally explained by biochemical dysregulation at the endometrial–myometrial interface, leading to passive displacement of endometrial stromal cells (ESCs). However, the uterus is a highly mechanosensitive organ. Aberrant myometrial hypercontractility in AM may expose ESCs to chronic mechanical stimulation. Whether such mechanical cues can modulate ESCs’ behavior under in vitro conditions remains incompletely understood. This study hypothesizes that cyclic mechanical strain—independent of biochemical cues—can induce a pro-migratory and pro-invasive ESC phenotype in vitro. Immortalized human ESCs (hESCs) were subjected to cyclic uniaxial stretching (12% strain, 0.2 Hz, 48 h) to model sustained mechanical loading. We evaluated cellular morphology, migration and invasion (wound healing and Transwell assays), cytoskeletal remodeling (F-actin), extracellular matrix (ECM) related proteins, transcriptomic changes (RNA-sequencing), and MAPK pathway activation. The functional involvement of p38 MAPK was tested using the selective inhibitor Adezmapimod. The results indicated that cyclic stretch induced marked cellular elongation without increasing apoptosis. RNA-sequencing revealed 580 differentially expressed genes enriched in migration and ECM remodeling. Functionally, stretched hESCs exhibited enhanced migration and invasion capacity in vitro, accompanied by elevated F-actin, fibronectin, and CTGF. Mechanistically, mechanical strain triggered selective activation of the p38 MAPK pathway, without affecting ERK or JNK. Pharmacological inhibition of p38 attenuated stretch-associated cytoskeletal remodeling, ECM-related protein expression, and cell motility. Together, these findings demonstrate that cyclic mechanical stretch, as an underexplored non-biochemical factor, can promote a motile and invasive stromal cell phenotype in vitro via a p38 MAPK/F-actin-associated mechanism. While these results do not establish causality for AM development in vivo, they suggest a potential mechanotransduction pathway through which abnormal uterine mechanics may influence stromal cell behavior. Targeting mechanotransduction—such as p38 inhibition—may represent novel mechano-therapeutics for AM. This warrants further investigation using more complex and physiologically relevant models.
- Open Access
- 27 October 2025
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 22 (16) , 4547-4560
Molecular mechanisms and Biological Functions of Autophagy in Endometrial Diseases
Autophagy is a highly conserved cellular process crucial for maintaining cellular homeostasis by degrading damaged organelles and misfolded proteins. Emerging evidence highlights its pivotal role in endometrial diseases, including endometriosis, endometritis, and endometrial cancer, where dysregulated autophagy contributes to pathogenesis through mechanisms such as altered hormone signaling, inflammation, and metabolic reprogramming. In this review, we comprehensively summarize the molecular machinery of autophagy, its regulatory networks, and its dual roles in endometrial physiology and pathology. Furthermore, we discuss the molecular mechanisms underlying autophagy in endometrial diseases, and the therapeutic potential of targeting autophagy pathways. By integrating recent advances, this review provides insights into autophagy's complex interplay with endometrial diseases and its implications for future research and therapeutic applications.
- 27 October 2025
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 22 (16) , 4547-4560
Open AccessMolecular mechanisms and Biological Functions of Autophagy in Endometrial Diseases
Autophagy is a highly conserved cellular process crucial for maintaining cellular homeostasis by degrading damaged organelles and misfolded proteins. Emerging evidence highlights its pivotal role in endometrial diseases, including endometriosis, endometritis, and endometrial cancer, where dysregulated autophagy contributes to pathogenesis through mechanisms such as altered hormone signaling, inflammation, and metabolic reprogramming. In this review, we comprehensively summarize the molecular machinery of autophagy, its regulatory networks, and its dual roles in endometrial physiology and pathology. Furthermore, we discuss the molecular mechanisms underlying autophagy in endometrial diseases, and the therapeutic potential of targeting autophagy pathways. By integrating recent advances, this review provides insights into autophagy's complex interplay with endometrial diseases and its implications for future research and therapeutic applications.
- Open Access
- 26 August 2025
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 18 (1) , 1-15
Impact of ovarian cystectomy on oncological and reproductive outcomes in borderline ovarian tumors: a retrospective study from a tertiary center
Fertility-sparing surgery (FSS) is commonly performed in patients with borderline ovarian tumors (BOT) due to their favorable prognosis. However, the long-term prognosis and pregnancy outcomes for these patients remain uncertain. This study aims to assess the feasibility of ovarian cystectomy (OC) and evaluate both oncologic and reproductive outcomes in BOT patients. A retrospective analysis of oncologic and reproductive outcomes was conducted on BOT patients who underwent OC at our department between July 1, 2007, and April 30, 2024, using univariate and multivariate analyses and survival curves. Among 85 patients in the study, 12 experienced recurrence post-ovarian cystectomy. High-risk indicators included ultrasound findings, CA-125 levels, extent of surgery, and histological type. Of the 45 who attempted pregnancy, 38 conceived successfully, though no specific factors significantly influenced pregnancy outcomes. Among patients with micropapillary serous borderline ovarian tumors (MP-sBOT), 8 did not receive chemotherapy, while 6 did. Recurrence (2/8 vs. 1/6, p = 0.707) and fertility outcomes (1/8 vs. 2/6, p = 0.347) were not significantly different between those who received adjuvant chemotherapy and those who did not. OC is the preferred fertility-preserving treatment for BOT patients, with laparoscopic ovarian cystectomy recommended for most young, reproductive-aged patients. Early conception and close monitoring are advised for those with bilateral or high-risk tumors, though more research is needed on managing pregnancy-associated BOT.
- 26 August 2025
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 18 (1) , 1-15
Open AccessImpact of ovarian cystectomy on oncological and reproductive outcomes in borderline ovarian tumors: a retrospective study from a tertiary center
Fertility-sparing surgery (FSS) is commonly performed in patients with borderline ovarian tumors (BOT) due to their favorable prognosis. However, the long-term prognosis and pregnancy outcomes for these patients remain uncertain. This study aims to assess the feasibility of ovarian cystectomy (OC) and evaluate both oncologic and reproductive outcomes in BOT patients. A retrospective analysis of oncologic and reproductive outcomes was conducted on BOT patients who underwent OC at our department between July 1, 2007, and April 30, 2024, using univariate and multivariate analyses and survival curves. Among 85 patients in the study, 12 experienced recurrence post-ovarian cystectomy. High-risk indicators included ultrasound findings, CA-125 levels, extent of surgery, and histological type. Of the 45 who attempted pregnancy, 38 conceived successfully, though no specific factors significantly influenced pregnancy outcomes. Among patients with micropapillary serous borderline ovarian tumors (MP-sBOT), 8 did not receive chemotherapy, while 6 did. Recurrence (2/8 vs. 1/6, p = 0.707) and fertility outcomes (1/8 vs. 2/6, p = 0.347) were not significantly different between those who received adjuvant chemotherapy and those who did not. OC is the preferred fertility-preserving treatment for BOT patients, with laparoscopic ovarian cystectomy recommended for most young, reproductive-aged patients. Early conception and close monitoring are advised for those with bilateral or high-risk tumors, though more research is needed on managing pregnancy-associated BOT.
- Open Access
- 19 February 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1490746
Shared diagnostic biomarkers and underlying mechanisms between endometriosis and recurrent implantation failure
Background: Endometriosis (EMs) is a common condition that causes dysmenorrhea, chronic pelvic pain, and infertility, affecting millions of women worldwide. Despite the use of assisted reproductive technology, EMs patients often experience lower embryo implantation rates and recurrent implantation failure (RIF) due to impaired uterine endometrial receptivity. This study aims to identify shared diagnostic genes and underlying mechanisms between EMs and RIF using integrated transcriptomic analysis and machine learning with Gene Expression Omnibus (GEO) datasets.Methods: We analyzed GSE11691, GSE7305, GSE111974, and GSE103465 as training datasets for EMs and RIF, and GSE25628 and GSE92324 as validation datasets. Differentially expressed genes (DEGs) and Weighted Gene Co-Expression Network Analysis (WGCNA) identified key genes specific to and shared by EMs and RIF. Machine learning algorithms were used to determine the shared diagnostic gene, whose performance was validated in both training and validation datasets. Single-gene Gene Set Enrichment Analysis (GSEA) revealed shared biological processes in EMs and RIF, while CIBERSORT analysis highlighted similarities and differences in immune infiltration between the two conditions. Finally, endometrial samples from healthy controls, EMs, and RIF patients were collected, and qRT-PCR was performed to validate the diagnostic gene.Results: We identified 48 shared key genes between EMs and RIF. The diagnostic gene EHF was selected through machine learning algorithms, and its diagnostic performance was validated in both training and validation datasets. ROC curve analysis demonstrated excellent diagnostic accuracy of EHF for both diseases. Gene Set Enrichment Analysis (GSEA) revealed that both conditions shared biological processes, including dysregulated extracellular matrix remodeling and abnormal immune infiltration. Furthermore, we validated the expression of EHF in endometrial samples from healthy controls, EMs, and RIF patients. Additionally, we characterized the immune microenvironment in EMs and RIF, highlighting changes in immune cell components associated with EHF.Discussion: The diagnostic gene EHF identified in this study may serve as a key link between EMs and RIF. The shared pathological processes in both conditions involve alterations in the extracellular matrix and subsequent changes in the immune microenvironment. These findings provide novel insights into potential therapeutic strategies for improving infertility treatment in patients with EMs.
- 19 February 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1490746
Open AccessShared diagnostic biomarkers and underlying mechanisms between endometriosis and recurrent implantation failure
Background: Endometriosis (EMs) is a common condition that causes dysmenorrhea, chronic pelvic pain, and infertility, affecting millions of women worldwide. Despite the use of assisted reproductive technology, EMs patients often experience lower embryo implantation rates and recurrent implantation failure (RIF) due to impaired uterine endometrial receptivity. This study aims to identify shared diagnostic genes and underlying mechanisms between EMs and RIF using integrated transcriptomic analysis and machine learning with Gene Expression Omnibus (GEO) datasets.Methods: We analyzed GSE11691, GSE7305, GSE111974, and GSE103465 as training datasets for EMs and RIF, and GSE25628 and GSE92324 as validation datasets. Differentially expressed genes (DEGs) and Weighted Gene Co-Expression Network Analysis (WGCNA) identified key genes specific to and shared by EMs and RIF. Machine learning algorithms were used to determine the shared diagnostic gene, whose performance was validated in both training and validation datasets. Single-gene Gene Set Enrichment Analysis (GSEA) revealed shared biological processes in EMs and RIF, while CIBERSORT analysis highlighted similarities and differences in immune infiltration between the two conditions. Finally, endometrial samples from healthy controls, EMs, and RIF patients were collected, and qRT-PCR was performed to validate the diagnostic gene.Results: We identified 48 shared key genes between EMs and RIF. The diagnostic gene EHF was selected through machine learning algorithms, and its diagnostic performance was validated in both training and validation datasets. ROC curve analysis demonstrated excellent diagnostic accuracy of EHF for both diseases. Gene Set Enrichment Analysis (GSEA) revealed that both conditions shared biological processes, including dysregulated extracellular matrix remodeling and abnormal immune infiltration. Furthermore, we validated the expression of EHF in endometrial samples from healthy controls, EMs, and RIF patients. Additionally, we characterized the immune microenvironment in EMs and RIF, highlighting changes in immune cell components associated with EHF.Discussion: The diagnostic gene EHF identified in this study may serve as a key link between EMs and RIF. The shared pathological processes in both conditions involve alterations in the extracellular matrix and subsequent changes in the immune microenvironment. These findings provide novel insights into potential therapeutic strategies for improving infertility treatment in patients with EMs.
- Open Access
- 15 October 2024
- Published by PAGEPress Publications in European Journal of Histochemistry
- Vol. 68 (4) , 335-342
The matrix stiffness is increased in the eutopic endometrium of adenomyosis patients: a study based on atomic force microscopy and histochemistry
Previous ultrasound studies suggest that patients with adenomyosis (AM) exhibit increased uterine cavity stiffness, although direct evidence regarding extracellular matrix (ECM) content and its specific impact on endometrial stiffness remains limited. This study utilized atomic force microscopy to directly measure endometrial stiffness and collagen morphology, enabling a detailed analysis of the endometrium’s mechanical properties: through this approach, we established direct evidence of increased endometrial stiffness and fibrosis in patients with AM. Endometrial specimens were also stained with Picrosirius red or Masson’s trichrome to quantify fibrosis, and additional analyses assessed α-SMA and Ki-67 expression. Studies indicate that pathological conditions significantly influence the mechanical properties of endometrial tissue. Specifically, adenomyotic endometrial tissue demonstrates increased stiffness, associated with elevated ECM and fibrosis content, whereas normal endometrial samples are softer with lower ECM content. AM appears to alter both the mechanical and histological characteristics of the eutopic endometrium. Higher ECM content may significantly impact endometrial mechanical properties, potentially contributing to AM-associated decidualization defects and fertility challenges.
- 15 October 2024
- Published by PAGEPress Publications in European Journal of Histochemistry
- Vol. 68 (4) , 335-342
Open AccessThe matrix stiffness is increased in the eutopic endometrium of adenomyosis patients: a study based on atomic force microscopy and histochemistry
Previous ultrasound studies suggest that patients with adenomyosis (AM) exhibit increased uterine cavity stiffness, although direct evidence regarding extracellular matrix (ECM) content and its specific impact on endometrial stiffness remains limited. This study utilized atomic force microscopy to directly measure endometrial stiffness and collagen morphology, enabling a detailed analysis of the endometrium’s mechanical properties: through this approach, we established direct evidence of increased endometrial stiffness and fibrosis in patients with AM. Endometrial specimens were also stained with Picrosirius red or Masson’s trichrome to quantify fibrosis, and additional analyses assessed α-SMA and Ki-67 expression. Studies indicate that pathological conditions significantly influence the mechanical properties of endometrial tissue. Specifically, adenomyotic endometrial tissue demonstrates increased stiffness, associated with elevated ECM and fibrosis content, whereas normal endometrial samples are softer with lower ECM content. AM appears to alter both the mechanical and histological characteristics of the eutopic endometrium. Higher ECM content may significantly impact endometrial mechanical properties, potentially contributing to AM-associated decidualization defects and fertility challenges.
- Open Access
- 8 October 2024
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 22 (1) , 1-16
Inhibition of HOXC11 by artesunate induces ferroptosis and suppresses ovarian cancer progression through transcriptional regulation of the PROM2/PI3K/AKT pathway
Ferroptosis, a non-apoptotic form of regulated cell death, plays a critical role in the suppression of various tumor types, including ovarian cancer. Artesunate (ART), a derivative of artemisinin, exhibits extensive antitumor effects and is associated with ferroptosis. This study aimed to investigate the mechanisms through which ART induces ferroptosis to inhibit ovarian cancer. RNA sequencing was conducted to identify differentially expressed genes associated with ART-induced ferroptosis. Dual-luciferase reporter assays and electrophoretic mobility shift assays were performed to confirm the interaction between Homeobox C11 (HOXC11) and the Prominin 2 (PROM2) promoter. Cell Counting Kit-8 (CCK-8) assays, flow cytometry, and wound healing assays were used to analyze the antitumor effects of ART. Western blot, biochemical assays and transmission electron microscope were utilized to further characterize ART-induced ferroptosis. In vivo, the effects of ART on ferroptosis were examined using a xenograft mouse model. RNA sequencing analysis revealed that the HOXC11, PROM2 and Phosphatidylinositol 3-Kinase/ Protein Kinase B (PI3K/AKT) pathways were downregulated by ART. HOXC11 was found to regulate PROM2 expression by binding to its promoter directly. HOXC11 overexpression reversed ART-induced effects on ovarian cancer cell proliferation, migration, apoptosis and ferroptosis by activating the PROM2/PI3K/AKT signaling axis. Conversely, silencing PROM2 in HOXC11-overexpressing cells restored ART-induced ferroptosis and its associated antitumor effects by inhibiting the PI3K/AKT pathway. Consistently, in vivo studies using a xenograft mouse model confirmed that ART-induced tumor inhibition was mediated by ferroptosis through the suppression of the HOXC11/PROM2/PI3K/AKT pathway. This study identifies the HOXC11/PROM2/PI3K/AKT axis as a novel regulatory mechanism underlying ART-induced ferroptosis in ovarian cancer. Targeting the HOXC11/PROM2 axis may represent a promising therapeutic strategy for enhancing ferroptosis, offering new insights for the treatment of ovarian cancer.
- 8 October 2024
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 22 (1) , 1-16
Open AccessInhibition of HOXC11 by artesunate induces ferroptosis and suppresses ovarian cancer progression through transcriptional regulation of the PROM2/PI3K/AKT pathway
Ferroptosis, a non-apoptotic form of regulated cell death, plays a critical role in the suppression of various tumor types, including ovarian cancer. Artesunate (ART), a derivative of artemisinin, exhibits extensive antitumor effects and is associated with ferroptosis. This study aimed to investigate the mechanisms through which ART induces ferroptosis to inhibit ovarian cancer. RNA sequencing was conducted to identify differentially expressed genes associated with ART-induced ferroptosis. Dual-luciferase reporter assays and electrophoretic mobility shift assays were performed to confirm the interaction between Homeobox C11 (HOXC11) and the Prominin 2 (PROM2) promoter. Cell Counting Kit-8 (CCK-8) assays, flow cytometry, and wound healing assays were used to analyze the antitumor effects of ART. Western blot, biochemical assays and transmission electron microscope were utilized to further characterize ART-induced ferroptosis. In vivo, the effects of ART on ferroptosis were examined using a xenograft mouse model. RNA sequencing analysis revealed that the HOXC11, PROM2 and Phosphatidylinositol 3-Kinase/ Protein Kinase B (PI3K/AKT) pathways were downregulated by ART. HOXC11 was found to regulate PROM2 expression by binding to its promoter directly. HOXC11 overexpression reversed ART-induced effects on ovarian cancer cell proliferation, migration, apoptosis and ferroptosis by activating the PROM2/PI3K/AKT signaling axis. Conversely, silencing PROM2 in HOXC11-overexpressing cells restored ART-induced ferroptosis and its associated antitumor effects by inhibiting the PI3K/AKT pathway. Consistently, in vivo studies using a xenograft mouse model confirmed that ART-induced tumor inhibition was mediated by ferroptosis through the suppression of the HOXC11/PROM2/PI3K/AKT pathway. This study identifies the HOXC11/PROM2/PI3K/AKT axis as a novel regulatory mechanism underlying ART-induced ferroptosis in ovarian cancer. Targeting the HOXC11/PROM2 axis may represent a promising therapeutic strategy for enhancing ferroptosis, offering new insights for the treatment of ovarian cancer.
- Open Access
- 27 March 2024
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 17 (1) , 1-12
CDCA5 promoted cell invasion and migration by activating TGF-β1 pathway in human ovarian cancer cells
Background: The gene cell division cycle associated 5 (CDCA5), also called sororin, has oncogenic characteristics and is upregulated in various carcinomas. Nevertheless, the involvement of CDCA5 in ovarian cancer (OC), a highly aggressive form of cancer, and the underlying mechanism of metastasis remain inadequately investigated. Results: The bioinformatics data revealed a negative correlation between the patient’s survival and CDCA5 expression, which was overexpressed in OC. Functional assays also confirmed high expression levels of CDCA5 in OC tissues and cells. This suggests that CDCA5 may potentially enhance the motility, migration, and proliferation of OC cells invitro. It impedes DNA damage and apoptosis in OC cells, inhibiting xenograft development in nude mice. The RNA sequencing results suggest CDCA5 is majorly associated with biological functions related to the extracellular matrix (ECM) and influences the transforming growth factor (TGF) signaling pathway. Moreover, subsequent functional investigations elucidated that CDCA5 facilitated the migration and invasion of OC cells viathe TGF-β1/Smad2/3 signaling pathway activation. Conclusions: CDCA5 may be a strong potential therapeutic target for the treatment and management of OC.
- 27 March 2024
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 17 (1) , 1-12
Open AccessCDCA5 promoted cell invasion and migration by activating TGF-β1 pathway in human ovarian cancer cells
Background: The gene cell division cycle associated 5 (CDCA5), also called sororin, has oncogenic characteristics and is upregulated in various carcinomas. Nevertheless, the involvement of CDCA5 in ovarian cancer (OC), a highly aggressive form of cancer, and the underlying mechanism of metastasis remain inadequately investigated. Results: The bioinformatics data revealed a negative correlation between the patient’s survival and CDCA5 expression, which was overexpressed in OC. Functional assays also confirmed high expression levels of CDCA5 in OC tissues and cells. This suggests that CDCA5 may potentially enhance the motility, migration, and proliferation of OC cells invitro. It impedes DNA damage and apoptosis in OC cells, inhibiting xenograft development in nude mice. The RNA sequencing results suggest CDCA5 is majorly associated with biological functions related to the extracellular matrix (ECM) and influences the transforming growth factor (TGF) signaling pathway. Moreover, subsequent functional investigations elucidated that CDCA5 facilitated the migration and invasion of OC cells viathe TGF-β1/Smad2/3 signaling pathway activation. Conclusions: CDCA5 may be a strong potential therapeutic target for the treatment and management of OC.
- 14 February 2024
- Published by Wiley in Cell Biology International
- Vol. 48 (5) , 647-664
Histological study of telocytes in mice intrauterine adhesion model and their positive effect on mesenchymal stem cells in vitro
Intrauterine adhesions (IUA), the main cause of secondary infertility in women, result from irreversible fibrotic repair of the endometrium due to inflammation or human factors, accompanied by disruptions in the repair function of endometrial stem cells. This significantly impacts the physical and mental health of women in their childbearing years. Telocytes (TCs), a distinctive type of interstitial cells found in various tissues and organs, play diverse repair functions due to their unique spatial structure. In this study, we conduct the inaugural exploration of the changes in TCs in IUA disease and their potential impact on the function of stem cells. Our results show that in vivo, through double immunofluorescence staining (CD34+/Vimentin+; CD34+/CD31−), as endometrial fibrosis deepens, the number of TCs gradually decreases, telopodes shorten, and the three‐dimensional structure becomes disrupted in the mouse IUA mode. In vitro, TCs can promote the proliferation and cycle of bone mesenchymal stem cells (BMSCs) by promoting the Wnt/β‐catenin signaling pathway, which were inhibited using XAV939. TCs can promote the migrated ability of BMSCs and contribute to the repair of stem cells during endometrial injury. In addition, TCs can inhibit the apoptosis of BMSCs through the Bcl‐2/Bax pathway. In conclusion, our study demonstrates, for the first time, the resistance role of TCs in IUA disease, shedding light on their potential involvement in endometrial repair through the modulation of stem cell function.
- 14 February 2024
- Published by Wiley in Cell Biology International
- Vol. 48 (5) , 647-664
Histological study of telocytes in mice intrauterine adhesion model and their positive effect on mesenchymal stem cells in vitro
Intrauterine adhesions (IUA), the main cause of secondary infertility in women, result from irreversible fibrotic repair of the endometrium due to inflammation or human factors, accompanied by disruptions in the repair function of endometrial stem cells. This significantly impacts the physical and mental health of women in their childbearing years. Telocytes (TCs), a distinctive type of interstitial cells found in various tissues and organs, play diverse repair functions due to their unique spatial structure. In this study, we conduct the inaugural exploration of the changes in TCs in IUA disease and their potential impact on the function of stem cells. Our results show that in vivo, through double immunofluorescence staining (CD34+/Vimentin+; CD34+/CD31−), as endometrial fibrosis deepens, the number of TCs gradually decreases, telopodes shorten, and the three‐dimensional structure becomes disrupted in the mouse IUA mode. In vitro, TCs can promote the proliferation and cycle of bone mesenchymal stem cells (BMSCs) by promoting the Wnt/β‐catenin signaling pathway, which were inhibited using XAV939. TCs can promote the migrated ability of BMSCs and contribute to the repair of stem cells during endometrial injury. In addition, TCs can inhibit the apoptosis of BMSCs through the Bcl‐2/Bax pathway. In conclusion, our study demonstrates, for the first time, the resistance role of TCs in IUA disease, shedding light on their potential involvement in endometrial repair through the modulation of stem cell function.
- 19 December 2023
- Published by Elsevier in Reproductive Biology
- Vol. 24 (1) , 100841
Knockdown of TXNIP alleviates gestational diabetes mellitus by activating autophagy to regulate cell proliferation and apoptosis in high glucose-treated trophoblasts
- 19 December 2023
- Published by Elsevier in Reproductive Biology
- Vol. 24 (1) , 100841
Knockdown of TXNIP alleviates gestational diabetes mellitus by activating autophagy to regulate cell proliferation and apoptosis in high glucose-treated trophoblasts